Hikma Ventures backs 3D-printing nutrition firm Rem3dy in first wellness bet
What's the deal? Hikma Pharmaceuticals'Dealroom has a profile for this one. Try Dealroom → corporate venture arm, Hikma VenturesDealroom has a profile for this one. Try Dealroom →, has made a strategic investment in Rem3dy Health, a UK company that uses 3D printing to make personalised nutrition products. The company, founded by Melissa Snover, produces multi-nutrient gummy "stacks" under its Nourished brand, combining up to seven dosed active ingredients into a single chewable. Terms were not disclosed.
What's the endgame? The investment pairs with an exclusive commercial deal to bring Nourished to the Middle East and North Africa, initially targeting Saudi Arabia and the United Arab Emirates. Hikma will use its regional presence and distribution to scale the brand across the region.
Why now? The move follows an October agreement under which Hikma will distribute Nourished across Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, and Jordan. Those products will form the core of Hikma's vitamins, minerals, and supplements portfolio, which it says meets rising regional demand for preventive health.
Rem3dy holds 29 patents covering its data-driven manufacturing technology. Its formulations are sugar-free, vegan, and allergen-free, targeting sleep, gut health, immunity, beauty, and cognitive wellbeing.
"Rem3dy Health combines differentiated technology, strong consumer engagement, and a compelling vision for personalised wellness," said Lana Ghanem, managing director of Hikma Ventures. Snover called the backing "a valued endorsement of our technology."
The deal marks Hikma Ventures' first investment in health and wellness innovation. Since inception, it has backed more than 20 healthcare companies spanning digital health, connected devices, telemedicine, diagnostics, and AI-enabled solutions.
Rem3dy's most recent reported financing was a £14 million raise in June 2026 at an £84 million valuation, backed by strategic investors including SuntoryDealroom has a profile for this one. Try Dealroom →, Estrella GaliciaDealroom has a profile for this one. Try Dealroom →, Apollo HospitalsDealroom has a profile for this one. Try Dealroom →, and UPSADealroom has a profile for this one. Try Dealroom →, to fund international expansion and manufacturing.
The signal: Hikma's bet reflects a broader pharma push beyond prescription drugs into consumer wellness, pairing venture capital with distribution muscle. By combining investment and commercial execution, it is positioning 3D-printed, personalised supplements as a growth channel in a region increasingly focused on preventive health.
Read more: hk.marketscreener.com
Image credit: Generated with Gemini
